The largest database of trusted experimental protocols

Nanoscan pet mri system

Manufactured by Mediso
Sourced in Hungary

The NanoScan PET/MRI system is a preclinical imaging device that combines positron emission tomography (PET) and magnetic resonance imaging (MRI) technologies. It enables simultaneous acquisition of PET and MRI data, providing comprehensive anatomical and functional information about small animal subjects.

Automatically generated - may contain errors

10 protocols using nanoscan pet mri system

1

Tumor Growth Monitoring with MRI

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor growth was monitored using magnetic resonance imaging (MRI) with a frequency depending on the tumor model and the corresponding growth rate (e.g., weekly imaging for U87_mCherry tumors and at least every two weeks for G7_mCherry). MRI examinations were acquired with a 1.0 Tesla nanoScan® PET/MRI system (Mediso Medical Imaging Systems, Budapest, Hungary) using the mouse head coil. For this purpose, Isoflurane (2–2.5% in oxygen; Baxter Germany) was used for anesthesia, and mice were positioned in the MRI bed with an integrated warming system. Bed temperature (37 °C), as well as breathing frequency, were monitored during the whole imaging procedure.
First, a T2-weighted 3D fast spin echo sequence with a field of view (FOV) covering the head of the mouse was performed (repetition time (TR): 1000 ms, effective echo time (TE): 97.7 ms, FOV: 31.3 mm, slice thickness: 0.23 mm, number of slices: 90). Second, a 3D gradient echo spoiled T1-weighted sequence was applied 10 min after i.p. injection of 5 mL/kg bw Omniscan® (GE Healthcare, Chicago, IL, USA) Gadolinium-based contrast agent at the same position (TR: 15 ms, TE: 3.1 ms, flip angle: 25°, FOV: 60 mm, slice thickness: 0.23 mm, number of slices: 90). Data were analyzed using the InterviewFusion™ software (Mediso Medical Imaging Systems, Budapest, Hungary); the investigator was blinded to the therapy at the moment of evaluation.
+ Open protocol
+ Expand
2

Preclinical MRI Acquisition and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
MR images were acquired by a NanoScan
PET/MRI system (Mediso, Budapest, Hungary), in which the MRI component
is a preclinical 1T MRI scanner (M2, Aspect Imaging) with a horizontal
bore magnet, a solenoid coil (diameter of 35 mm), and a 450 mT/m gradient.
Mice were anesthetized using 1.5% isoflurane with medical air at a
flow rate of 2 L/min and placed on the MRI scanner bed. T2-weighted MR scans were performed using a fast spin echo
(FSE) sequence with the following parameters: TR/TE = 10960/55.6 ms,
flip angle 90°, slice thickness 1 mm, FOV 100 × 35 mm2, 300 × 96 matrix. T1-weighted MR scans were
performed using a gradient echo (GRE) sequence with the following
parameters: TR/TE = 702/6.4 ms, flip angle 90°, slice thickness
1 mm, FOV 100 × 35 mm2, 300 × 100 matrix. MRI
images were visualized and analyzed via InterView Fusion software
(Mediso, Budapest, Hungary). In vivo signal-to-noise
ratios (SNRs) were calculated for different ROIs. SNRs were calculated
using the equation SNR = 0.655 × S/σ,41 (link) where S denotes the average
signal of the ROI and σ is the noise defined as the standard
deviation of the signal in an ROI placed in background air (free of
ghosting artifacts).
+ Open protocol
+ Expand
3

Quantitative PET/MRI Imaging of Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
PET/MRI fused imaging was performed using the nanoScan PET/MRI system (1T, Mediso, Hungary). Mice were fasted for 8 h before imaging, maintained at a constant body temperature, and injected intravenously via the tail vein with 6.5 ± 1.0 MBq in 0.2 mL of FDG. Mice were kept under anaesthesia (1.5% isoflurane in 100% O2 gas). The T1-weighted with Gradient-echo (GRE) 3D sequence (TR = 25 ms, TEeff = 3.4, FOV = 64 mm, matrix = 128 × 128) was acquired during the FDG uptake period. Static PET images were acquired for 10 min in a 1–5 coincident in a single field of view in the MRI range. Body temperature was maintained with a heating pad on the animal bed (Multicell, Mediso, Hungary) and a pressure sensitive pad was used for respiratory triggering. PET images were reconstructed by Tera-Tomo 3D in full detector mode with all the corrections on, high regularisation, and eight iterations. Three-dimensional volume of interest (VOI) analysis of the reconstructed images was performed using the InterView Fusion software package (Mediso, Hungary) and applying standard uptake value (SUV) analysis. The VOI was fixed in a sphere of 2 mm diameter, which was drawn for the tumour and muscle sites. The SUV of each VOI site was calculated using the following formula SUV mean = (tumour radioactivity in the tumour VOI with the unit of Bq/cc × body weight) divided by injected radioactivity59 (link).
+ Open protocol
+ Expand
4

Imaging of HER3 Expression in Xenograft Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The labeling of (HE)3-Z08698-NODAGA with gallium-68 and micro positron emission tomography (microPET)/computed tomography (CT) imaging of HER3 expression in xenografted mice were done according to a published protocol [27 (link)]. Briefly, whole body PET scans of the BxPC-3 xenografted mice were performed under general anesthesia in a nanoScan PET/MRI system (Mediso Medical Imaging Systems Ltd., Budapest, Hungary) 1 h post i.v. injection of 2 µg of the anti-HER3 affibody imaging probe [68Ga]Ga-(HE)3-Z08698-NODAGA (1.6–7.3 MBq). CT acquisitions were performed using a nanoScan SPECT/CT system (Mediso Medical Imaging Systems Ltd., Budapest, Hungary) immediately after PET acquisition using the same bed position. PET scans were performed for 30 min. PET data were reconstructed into a static image using a Tera-Tomo™ 3D reconstruction engine. CT data were reconstructed using filtered back projection. PET and CT files were fused and analyzed using Nucline 2.03 Software. Imaging was performed one day after therapeutic injection.
+ Open protocol
+ Expand
5

Adipose Tissue Measurement via MRI

Check if the same lab product or an alternative is used in the 5 most similar protocols
Information on adipose tissues obtained by MRI measurement was collected using NanoScan PET/MRI system (Mediso Ltd, Hungary). Mice were anesthetized with isoflurane and underwent MRI without using contrast material. Parameters used: scan range 100 mm, 250 slice, slice thickness 0,4, FO,V 50, matrix 128 × 128, NEX 3, TR/TE/FA 4.4/1.5/60 FESS were allowed.
+ Open protocol
+ Expand
6

Atherosclerosis Imaging in ApoE-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
ApoE−/− mice were maintained on a standard diet (n = 5) or on an atherogenic diet (n = 5) for 8 weeks to develop atheromatous plaques within the aorta. 68Ga-DFC was administered via the lateral tail vein in 0.15 mL volume after mice were anesthetized with 3% isoflurane with a dedicated small animal anesthesia device. Entire body PET scans (10 min static PET scans) were acquired using the preclinical nanoScan PET/MRI system (Mediso Ltd., Budapest, Hungary) 30 min after the 68Ga-DFC administration. To prevent the motion of the animals, mice were fixed to a mouse chamber (MultiCell Imaging Chamber, Mediso Ltd., Budapest, Hungary) and positioned in the center of the field of view (FOV). For the determination of the anatomical localization of the organs and tissues, T1-weighted MRI scans were performed (3D GRE EXT multi-FOV; TR/TE 15/2 ms; FOV 40 mm; NEX 2). PET volumes were reconstructed using a three-dimensional Ordered Subsets Expectation Maximization (3D-OSEM) algorithm (Tera-Tomo, Mediso Ltd., Hungary). PET and MRI images were automatically coregistered by the PET/MRI instrument’s acquisition software (Nucline). Reconstructed, reoriented and coregistered images were further analyzed with InterView™ FUSION (Mediso Ltd., Hungary) image analysis software.
+ Open protocol
+ Expand
7

In vivo PET/MRI Imaging of Tumor-bearing Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vivo imaging studies, healthy control and KB tumor-bearing CB17 SCID mice were injected with 8.42 ± 0.38 MBq of 68Ga- or 44Sc-labeled DO3AM-NI via the lateral tail vein 13 ± 1 days after the inoculation of KB tumor cells. Then, 65 and 225 min after radiotracer injection, mice were anaesthetized by 3% isoflurane (Forane) with a dedicated small animal anesthesia device and whole-body T1-weighted MRI scans were performed (3D GRE EXT multi-FOV; TR/TE 15/2 ms; phase: 100; FOV 60 mm; NEX 2) using the preclinical nanoScan PET/MRI system with 1 Tesla magnetic field (Mediso Ltd., Hungary). After MRI imaging, 20 min static whole-body PET scans were acquired (90 min and 4 h after radiotracer injection).
+ Open protocol
+ Expand
8

Longitudinal PET Imaging of Aged Mouse Brains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five mice in each group were given PET scans at the age of 10 months and 13 months. After fasting for 12 h, mice were anesthetized with isoflurane (4% for induction, 2% for maintenance) supplemented with oxygen, and [18]F-FDG was intraperitoneally injected. The injection dose and body weight of each mouse were recorded. Approximately 40 min later, the mice were anesthetized again and scanned using a nanoScan PET/MRI system (Mediso, Hungary). During scanning, mice were placed on a 37 ℃ constant temperature bed, and their respiratory rates were continuously monitored. MRI-based attenuation correction PET images were reconstructed with Nucline software (Bioscan, USA). PET images were matched to a predefined mouse brain atlas template (Additional file 1: Fig. S1a), and the standardized uptake value (SUV) of the volume of interest (VOI) was calculated for semiquantitative analysis using POMD v.3.4 (PMOD Technologies, Switzerland) [SUV = VOI activity concentration (Bq/cm)/(injected dose (Bq)/body weight (g))].
+ Open protocol
+ Expand
9

PET Imaging of Tumor Mouse Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Control and tumor-bearing animals were injected with 10.3±0.3 MBq of 68 Ga-NODAGA-PCA or 68 Ga-HBED-CC-PCA via the lateral tail vein. 90 min after radiotracer injection mice were anaesthetized by 3% isoflurane (Forane) with a dedicated small animal anesthesia device and whole body PET scans (20-min static PET scans) were acquired using the preclinical nanoScan PET/MRI system (Mediso Ltd., Hungary). To prevent movement, animals were fixed into a mouse chamber (MultiCell Imaging Chamber, Mediso Ltd., Hungary
+ Open protocol
+ Expand
10

In-vivo Mn-52 PET Imaging of Cervix Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
KB-3-1 cervix carcinoma tumor-bearing mice were anesthetized by 1.5% isoflurane, and for the anatomical localization of the investigated tissues, whole-body MRI scans (T1-weighted) were performed using the preclinical nanoScan PET/MRI system (Mediso Ltd., Budapest, Hungary). The 3D GRE EXT multi-FOV MRI parameters were set as follows: TR/TE 15/2 ms; phase: 100; FOV 60 mm; NEX 2. After MRI imaging, animals were injected intravenously with 9.43 ± 1.03 MBq of 52MnCl2, [52Mn]Mn-DOTAGA, or [52Mn]Mn-DOTAGA-bevacizumab and dynamic PET scans were performed. The co-registered and reconstructed (3D-OSEM algorithm with Tera-Tomo reconstruction software, Mediso Ltd., Budapest, Hungary) decay-corrected PET images were analyzed by the InterView™ FUSION (Mediso Ltd., Budapest, Hungary) image analysis software. Volumes of Interest (ellipsoidal 3-dimensional VOIs) were manually drawn around the edge of the activity of the investigated tissues and organs by visual inspection. The accumulation of the 52Mn-labeled probes was expressed in terms of standardized uptake values (SUVs).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!